- Régina A, Jodoin J, Khoueir P, Rolland Y, Berthelet F, Moumdjian R, Fenart L, Cecchelli R, Demeule M and Béliveau R (2004) Down-regulation of caveolin-1 in glioma vasculature: modulation by radiotherapy. J Neurosci. Res. 75:291-299.
- Gingras D, Labelle D, Carine N, Boivin D, Demeule M, Barthomeuf C and Béliveau R (2004) The antiangiogenic agent Neovastat (AE-941) stimulates tissue plasminogen activator activity. Invest. New drugs. 22:17-26.
- Turcotte S, Desrosiers RR and Béliveau R (2004) Hypoxia upregulates von Hippel-Lindau tumor-suppressor protein through RhoA-dependent activity in renal cell carcinoma. Am J Physiol Renal Physiol. 286:F338-F348.
- Gingras D, Gendron M, Boivin D, Moghrabi A, Théoret Y and Béliveau R (2004) Induction of medulloblastoma cell apoptosis by sulforaphane, a dietary anticarcinogen from Brassica vegetables. Cancer Lett. 203:35-43.
- Langlois S, Gingras D and Béliveau R (2004) Membrane type 1-matrix metalloproteinase (MT1-MMP) cooperates with sphingosine 1-phosphate to induce endothelial cell migration and morphegenic differentiation. Blood 103:3020-3028.
- Annabi B, Thibeault S, Moumdjian R and Béliveau R (2004) Hyaluronan cell surface binding Is induced by type I collagen and regulated by caveolae in glioma cells J. Biol. Chem., 279: 21888 - 21896.
- Gingras D, Nyalendo C, Di Tomasso G, Annabi B and Béliveau R (2004) Activation of tissue plasminogen activator gene transcription by Neovastat, a multifunctional antiangiogenic agent. Biochem. Biophys. Res Commun. 320:205-212.
- Lacourcière Y, Béliveau R, Conter HS, Burgess ED, Lepage S, Pesant Y, Spence JD, Asmar R, Carrière S, Plante GE (2004) Canadian Hypertension Society. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension. Can J Cardiol 20(8):795-799.
- Béliveau R and Gingras D (2004) Green tea: prevention and treatment of cancer by nutraceuticals. Lancet364:1021-2.
- Turcotte S, Desrosiers RR, Brand G and Béliveau R (2004) Hypoxia upregulates von Hippel-Lindau tumor suppressor protein stimulation by thrombin involves RhoA activation. Int. J. Cancer 112: 777-786.
- Demeule M, Regina A, Annabi B, Bertrand Y, Bojanowky and Béliveau R (2004) Brain endothelial cells as pharmacological targets in brain tumors. Mol Neurobiol. 30:157-184.
- Laplante I, Béliveau R, Paquin J (2004) RhoA/ROCK and Cdc42 regulate cell-cell contact and N-cadherin protein level during neurodetermination of P19 embryonal stem cells. J Neurobiol 60:289-307.
- Demeule M, Brossard M, Turcotte S, Regina A, Jodoin J, Béliveau R (2004) Diallyl dusulfide a chemopreventive agent in garlic induces multidrug-resistance associated protein 2 expression Biochem Biophys Res Comm 324: 937-945.
- Caron A, Desrosiers RR, Béliveau R (2004) Kidney ischemia-reperfusion regulates expression and distribution of tubulin subunits, beta-actin and rho GTPases in proximal tubules. Arch Biochem Biophys 431:31-46.
- Boivin D, Provençal M, Gendron S, Ratel D, Demeule M, Gingras D, and Béliveau R (2004) Purification and characterization of a stimulator of plasmin generation from the antiangiogenic agent Neovastat: identification as immunoglobulin Kappa light chain. Arch. Biochem. Biophys. 431 :197-206.
- Barthomeuf C, Boivin D, Béliveau R (2004) Inhibition of HUVEC tubulogenesis by hederacolchiside-A1 is associated with plasma membrane cholesterol sequestration and activation of Ha-Ras/MEK/ERK cascade. Cancer Chemother Pharmacol. 54:432-440.
Publications 2004
Resources
Sign Up and stay in the know
Most frequently visited pages
Survey
News Flash!
There are no translations available. Une analyse, récemment parue dans le Journal de l'Institut national du cancer américain, indique que les patients qui sont touchés par le cancer devraient éviter de consommer des suppléments d'antioxydants pendant les traitements de radiothérapie et de chimiothérapie. Télécharger la chronique. |
Who is online?
We have 243 guests online
